2015 February Evaluation Summaries - Baptist Health South ... · 2. Effectiveness of learning aids used (audio-visual, etc.) 3. Conference content. 4. Effectiveness of the speaker:

Continuing Medical Education Department CME Conference Evaluation Summaries

October 2014 - February 2015

CONTINUING MEDICAL EDUCATION

11/11 Pediatric Emergency Department Conference Series: Orthopedic Updates 5.0

11/13 Ob/Gyn Conference and Florida Perinatal Quality Collaborative: Obstetric Hemorrhage Initiative-Quality Improvement in Obstetric Hemorrhage Management 4.8

11/14 Ob/Gyn Conference Series: Gynecologic Oncology – Update for the Generalists Ob/Gyn 5.0

11/18 Dentistry & Medicine Conference Series: Practical Management of Common Medical Emergencies in the Dental Office 4.8

11/20 Cardiovascular Conference: Acute Coronary Syndromes: From Pathophysiology to Real-time Treatment 4.9

Symposiums

10/11 Second Annual Breast Cancer Symposium 4.9

10/31 33r Annual Echocardiography Symposium 4.5

11/15 12th Annual Sleep Center Symposium 4.9

12/5 2014 Miami Neuro Symposium 4.8

12/13 Venous Thromboembolism Symposium, Inaugural 4.9

CONTINUING

Conference Title: Pediatric Emergency Department Conference Series: Orthopedic Updates Conference Director: Pooya Hosseinzadeh, M.D. Date: Tuesday, November 11, 2014 Time : 6:00 Location: Baptist Hospital, Auditorium and videoconference to Homestead Hospital, Boardroom

Scoring Key: 5 - Strongly Agree 4 - Agree 3 -

1. As a result of attending this conference, to what extent do you agree that you will be better able to:

Update on Supracondylar Humerus Fractures in Childr en

• Examine the benefits of lateral entry only pin constructs.

• Describe the optimal pin configuration.

• Define criteria for and acceptable reduction.

• Describe the treatment regimen for a perfused, pulseless supraconyflar humerous fracture.

Developmental Dysplasia of the Hip: What's Old? What's New?

• Identify the risk factors for development of hip dysplasia.

• Explain the physical examination maneuvers for assessing newborn hip stability.

• Recognize indications for ultrasonography of the neonatal

• Describe the treatment modalities for newborn hip dysplasia.

Scoring Key: 5 - Excellent 4 - Very Good

2. Effectiveness of learning aids used (audio-visual, etc.)

3. Conference content.

4. Effectiveness of the speaker:

• Steven Frick, M.D.

5. Was this conference fair, balanced and without

What do you intend to do differently in the treatment of your patients as a result of wh at you learned at this conference? What new strategies will you apply in your practice of patient care?

• Increase use of ultrasounds in female and breech babies for dys• Closer follow-up. • Learned more screening tools. • Screen more newborns more attentively.

If you do not plan to implement any new strategies learned at this conference, please list any barrier s or obstacles that might keep you from doing so:

• None listed. List topics related to this lecture that you want t o learn more about:

• Fracture reductions. • ICD-10.

CONTINUING MEDICAL EDUCATION EVALUATION SUMMARY

Pediatric Emergency Department Conference Series: Orthopedic Updates

Pooya Hosseinzadeh, M.D.

: 6:00 – 7:00 p.m.

Baptist Hospital, Auditorium and videoconference to Homestead Hospital, Boardroom

- Neutral 2 - Disagree 1 - Strongly Disagree N/A- Not applicable for my practice


Update on Supracondylar Humerus Fractures in Childr en

benefits of lateral entry only pin constructs.

Describe the treatment regimen for a perfused, pulseless supraconyflar humerous fracture.

Dysplasia of the Hip: What's Old? What's New?

Identify the risk factors for development of hip dysplasia.

Explain the physical examination maneuvers for assessing newborn hip stability.

Recognize indications for ultrasonography of the neonatal hip.

Describe the treatment modalities for newborn hip dysplasia.

Very Good 3 - Good 2 - Fair 1 – Poor N/A- Not applicable

visual, etc.) if applicable.

Total Average:

commercial bias?

in the treatment of your patients as a result of wh at you learned at this What new strategies will you apply in your practice of patient care?

Increase use of ultrasounds in female and breech babies for dysplasia of the hip (DDH).

Screen more newborns more attentively.

If you do not plan to implement any new strategies learned at this conference, please list any barrier s or obstacles that

List topics related to this lecture that you want t o learn more about:

Not applicable for my practice

5.0

5.0

5.0

5.0

5.0

5.0

5.0

5.0

Not applicable

5.0

5.0

5.0

Total Average: 5.0

Yes 29 No 0 No response 3

in the treatment of your patients as a result of wh at you learned at this


Comments : • Excellent conference. • Thanks.

Baptist Hospital

Attendance : 33 Physicians: 24 BHSF Employees: 7 Other: 2

Homestead Hospital Attendance : 9 Physicians: 8 BHSF Employees: 1 Other: 0

Total Attendance : 42 Physicians: 32 BHSF Employees: 8 Other: 2

Conference Title: Ob/Gyn Conference and Florida Improvement in Obstetric Hemorrhage Management Conference Coordinator: Kim Zimmerman, R.N. Date: Thursday, November 13, 2014 Time :

Scoring Key: 5 - Strongly Agree 4 - Agree 3


• Explain the Florida Obstetric Hemorrhage Initiative (OHI) including supporting change, major objectives, and how to access the toolkit.

• Recognize the advantages of quantitative blood loss measurement, the value of debriefing following a hemorrhage event and why participation in a hemorrhage when implementing OHI.

• Implement the Florida Perinatal Quality Collaborative OHI to improve patient outcomes.

Scoring Key: 5 - Excellent 4 - Very Good

2. Effectiveness of learning aids used (audio-



• Judette Louis, M.D., MPH


How many patients will you see in your practice activity?

Number of Patients: 1-5 6-10

Respondents: 3 1

Percent (rounded): 19% 6%

What do you intend to do differently in the treatment of your patients as a result of wh at you learned at this conference?What new strategies will you apply in your practice of patient care?

• Follow protocol. (2) • Better screening and assessment. • Review protocols for hemorrhage. • Will approach patient differently.


• None listed. List topics related to this lecture that you want t o learn more

• Maternal death and morbidity related to pre• Spontaneous abortion.

Comments :

• Excellent conference. • Great presentation.

CONTINUING MEDICAL EDUCATIONEVALUATION SUMMARY

and Florida Perinatal Quality Collaborative: Obstetric Hemorrhage InitiativeImprovement in Obstetric Hemorrhage Management

Kim Zimmerman, R.N.

: 6:00 – 7:00 p.m. Location: South Miami Hospital, Classroom E and Webcast

3 - Neutral 2 - Disagree 1 - Strongly Disagree N/A- Not applicable for my


Explain the Florida Obstetric Hemorrhage Initiative (OHI) including evidence-based data-supporting change, major objectives, and how to access the toolkit. Recognize the advantages of quantitative blood loss measurement, the value of debriefing following a hemorrhage event and why participation in a hemorrhage simulation drill is necessary

Implement the Florida Perinatal Quality Collaborative OHI to improve patient outcomes.

Very Good 3 - Good 2 - Fair 1 – Poor N/A- Not ap

-visual, etc.) if applicable.

Total Average:

without commercial bias?

in your practice next week that will likely be impacted by what you learn ed at this

Over 10 No Answer Not applicable to my practice

4 3 5

25% 19% 31%

in the treatment of your patients as a result of wh at you learned at this conference?What new strategies will you apply in your practice of patient care?


List topics related to this lecture that you want t o learn more about: Maternal death and morbidity related to pre-eclampsia and hypertension.


Hemorrhage Initiative-Quality

South Miami Hospital, Classroom E and Webcast



4.8

simulation drill is necessary 4.8

4.8

Not applicable

4.8

4.8

4.8

Total Average: 4.8


week that will likely be impacted by what you learn ed at this

applicable to my practice

in the treatment of your patients as a result of wh at you learned at this conference?


Baptist Hospital -Live Attendance : 31 Physicians: 16 BHSF Employees: 14 Other: 1


Webcast Attendance : 1 Physicians: 0 BHSF Employees: 1 Other: 0

Conference Title: Ob/Gyn Conference Series: Conference Coordinator: Jason James, M.D. Date: Friday, November 14, 2014 Time : 8:00

Scoring Key: 5 - Strongly Agree 4 - Agree


• Assess pre-malignant conditions and follow appropriate referral indications.

• Explain recent changes in gynecologic cancer evaluation, diagnosis and

Scoring Key: 5 - Excellent 4 -




• Troy A. Gatcliffe, M.D., F.A.C.O.G., F.A.C.S.




Respondents: 13 6



• Order HE4 marker. (9) • Use ROMA. (4) • Take out tubes. • Consider biomarker testing.



• ROMA testing. Comments :

• Great presentation for something we do daily.• Very interesting and helpful.

CONTINUING MEDICAL EDUCATION

EVALUATION SUMMARY

Series: Gynecologic Oncology – Update for the Generalists Ob/Gyn

Jason James, M.D.

8:00 – 9:00 a.m. Location: Baptist Hospital of Miami, Auditorium

Agree 3 - Neutral 2 - Disagree 1 - Strongly Disagree N/A-

a result of attending this conference, to what extent do you agree that you will be better able to:

malignant conditions and follow appropriate referral indications.

Explain recent changes in gynecologic cancer evaluation, diagnosis and treatment advances.

Very Good 3 - Good 2 - Fair 1 – Poor N/A-


Troy A. Gatcliffe, M.D., F.A.C.O.G., F.A.C.S.

Total Average:




1 2 0

5% 9% 0%




Great presentation for something we do daily.

Baptist Hospital AttendancePhysicians: BHSF Employees: Other: 4


Update for the Generalists Ob/Gyn

Baptist Hospital of Miami, Auditorium



5.0

treatment advances. 5.0

Not applicable

5.0

5.0

5.0

Total Average: 5.0



Not applicable to my practice



Baptist Hospital Attendance : 49 Physicians: 22

Employees: 23

Conference Title: Dentistry & Medicine Conference Series: Dental Office Conference Director: Fred Pedroletti, DMD Date: Tuesday, November 18, 2014 Time



• Manage common medical emergencies seen in the dental practice setting.

• Discuss concepts and implement required access and office preparedness.

• Discuss treatments for specific emergencies and where appropriate the drugs used.

• Recognize signs and symptoms of relevant medical emergencies.

• Outline routes of drug administration appropriate to dental practitioners.

Scoring Key: 5 - Excellent 4 -




• Charles H. Kates, DDS




Respondents: 5 0



• Better health history. • Office protocol for emergencies. • Provide a treatment paper after emergencies.• Improve data collection and documentation.



• None listed.


Dentistry & Medicine Conference Series: Practical Management of Common Medical Emergencies in the

Time : 6:30 – 7:30 p.m. Location: Baptist Hospital, 5 MCVI

Agree 3 - Neutral 2 - Disagree 1 - Strongly Disagree N/A-


Manage common medical emergencies seen in the dental practice setting.

Discuss concepts and implement required skill sets for basic airway management, intravenous

Discuss treatments for specific emergencies and where appropriate the drugs used.

Recognize signs and symptoms of relevant medical emergencies.

s of drug administration appropriate to dental practitioners.

Very Good 3 - Good 2 - Fair 1 – Poor N/A-


Total Average:




1 7 2

7% 47% 13%


Provide a treatment paper after emergencies. Improve data collection and documentation.




Practical Management of Common Medical Emergencies in the

Baptist Hospital, 5 MCVI



4.7

skill sets for basic airway management, intravenous 4.7

4.7

4.7

4.7

Not applicable

5.0

5.0

5.0

Total Average: 4.8






Comments : • Seminars like this one should be done more often. • It’s a very important topic.

Attendance : 17 Dentists: 13 Physicians: 2 BHSF Employees: 2 Other: 0

CME ACTIVITY TITLE: Cardiovascular Conference: Treatment CONFERENCE DIRECTOR: Jonathan Roberts, M.D. DATE: Thursday, November 20, 2014 LOCATION: BHM, 5BCVI and Live Webcast



• Explain the pathogenesis of acute coronary syndromes (ACS).

• Identify critical issues associated with the management of highsegment elevation myocardial infarction (NSTEMI) and STEMI.

Scoring Key: 5 - Excellent

2. Effectiveness of learning aids used (audio



• Gregg W. Stone M.D.

5. Was this conference fair, balanced and


Number of Patients: 1-5 6

Respondents: 6 2



• Educate patients to call for help early.• Pharmacologic treatment for acute coronary syndromes.• Assess newer stents and pharmaceuticals that will best affect patient outcome.• Appropriate antibiotic treatment for STEMI.



• Treatment of chronic, stable angina.• Simulation topics.

Comments :


Cardiovascular Conference: Acute Coronary Syndromes: From Pathophysiology to Real

Jonathan Roberts, M.D.

Thursday, November 20, 2014 TIME: 12 noon – 1 p.m.

BHM, 5BCVI and Live Webcast VC to: SMHC Conf. Rm, WKBH CL 3, HH Pineapple Room

Agree 3 - Neutral 2 - Disagree 1 - Strongly Disagree N/A


Explain the pathogenesis of acute coronary syndromes (ACS).

Identify critical issues associated with the management of high-risk ACS, such as non-segment elevation myocardial infarction (NSTEMI) and STEMI.

Excellent 4 - Very Good 3 - Good 2 - Fair 1 – Poor N/A

2. Effectiveness of learning aids used (audio-visual, etc.) if applicable.

Total Average:

and without commercial bias?


6-10 Over 10 No Answer Not

2 2 18 5

6% 6% 55% 15%


Educate patients to call for help early. Pharmacologic treatment for acute coronary syndromes.

ss newer stents and pharmaceuticals that will best affect patient outcome. Appropriate antibiotic treatment for STEMI.

If you do not plan to implement any new strategies learned at this conference, please list any barrier s or obstacles

List topics related to this lecture that you want t o learn more about: Treatment of chronic, stable angina.


Pathophysiology to Real-time

1 p.m.

SMHC Conf. Rm, WKBH CL 3, HH Pineapple Room

N/A- Not applicable for my practice


4.9

ST- 4.9

N/A- Not applicable

4.9

4.9

4.9

Total Average: 4.9




%


If you do not plan to implement any new strategies learned at this conference, please list any barrier s or obstacles

• Excellent conference. (3) • Dr. Stone gave a great presentation. (2) • Terrific speaker and contents of information. • Perhaps speaker went a little too fast to absorb the content of the talk. I would suggest increasing the time of the

conference. • Handouts.

Baptist Hospital -Live Attendance : 54 Physicians: 22 BHSF Employees: 27 Other: 5


South Miami Hospital -VC Attendance : 5 Physicians: 1 BHSF Employees: 3 Other: 1

Homestead Hospital -VC Attendance : 12 Physicians: 10 BHSF Employees: 0 Other: 2

CONTINUING MEDICAL EDUCATION DEPARTMENT

Second Annual Breast Cancer Symposium October 11, 2014

Physicians Attended: 83

Physicians Responded: 70

Intraoperative Radiation Therapy

Cristina Lopez-Penalver, M.D. 4.8

• Identify patient selection criteria indicators for intraoperative radiation therapy (IORT). 4.8

• Assess the benefit of implementing an IORT technique. 4.8

Surgical Procedures of the Breast: Yesterday, Today and Tomorrow

Gladys L. Giron, M.D., FACS 4.8

• Examine options for surgical treatment of benign and malignant breast conditions.

• Determine appropriate treatment for patients presenting with benign breast disease. 4.8

• Identify patients who are not suitable candidates for surgical procedures. 4.8

Pre-Malignant Lesions

Andrew Renshaw, M.D. 4.9

• Assess and distinguish papillary lesions requiring a biopsy and those that can be

monitored. 4.9

• Describe the risk associated with a diagnosis of lobular carcinoma in situ on a breast core

needle biopsy. 4.9

Current State of Medical Oncology

Sara M. Garrido, M.D., FACP 4.8

• Analyze and explain recommendations of adjuvant therapy for women with hormone

receptor-positive breast cancer. 4.8

Implement new developments in the treatment of metastatic breast cancer, integrating the most

recent data into clinical practice. 4.8

Radiation Therapy in the Treatment of Breast Cancer

Andre A. Abitbol, M.D. 4.5

• Identify radiation therapy options and guidelines for patients undergoing mastectomy

and axillary lymph node biopsy dissection with positive lymph nodes. 4.5

• Explain the role of adjuvant radiation therapy following neoadjuvant chemotherapy and

mastectomy. 4.5

3D Mammography: The Latest Developments in the Breast Imaging Area

Katharine Lampen-Sachar, M.D. 4.8

• Identify indications and potential uses of breast tomosynthesis. 4.8

• Explain the potential benefits of breast tomosynthesis as well as some of the criticisms. 4.9

Total Average 4.8

Was this symposium fair, balanced, and free of commercial bias?

• Nothing listed.

Yes 61

No 1

No Answer 8

How many patients will you see in your practice next week that will likely be impacted by what you learned at

this symposium?

31 1-5(44%) 9 6-10 (13%) 12 Over 10 (17%) 18 No Answer(25%)

Scoring Key: 5 - Excellent 4 - Very Good 3 - Good 2 - Fair 1 - Poor

1. Overall impression of symposium. 4.7

2. Meeting Facilities.

• Location 4.5

• Symposium Registration 4.6

• Meeting Room 4.1

Total Average 4.5

How did you hear about this meeting?

(51%) Email (36)

(44%) Mail (31)

(3%) Internet (2)

(11%) Other (8)

Yes No No Answer

Would you attend this symposium again next year? (59) 84% (1) 1% (10) 14%

Would you recommend this symposium to a colleague?

(56) 80% (0) 0% (14) 20%

What do you intend to do differently in the treatment of your patients as a result of what you learned at this symposium?

What new strategies will you apply in your practice of patient care?

• Better communication treating patients.

• Better understanding of biopsy results /medical oncology.

• Find out if patients are at risk.

• More aggressive diagnostic tests and screening.

• Apply information learned today.

• Intra operative radiation treatment.

• Initiate a discussion with patients on their treatment choices depending on their condition.

• Discuss core biopsy results with pathologist more often.

• Understand better treatment my patients are undergoing.

• Educate patients more.

• In my 55 years of practice I apply everything.

• Not my patient population will share information with colleagues.

• Get good pathology info.

• I recommend Deep Venous Thrombosis (DVT).

• Consider intra-operative radiation therapy.

• Pay more attention to pathology report and now it will influence treatment.

• May refer patients to Dr. Penalver for Intra-operative radiation therapy (IORT).

• Have patients consider Intra-operative radiation therapy (IORT).

• Potential of IORT and criteria.

• Provide better information to breast reconstruction patients.

• It helps me better educate patients about their overall care and options.

• I continue auxiliary dissection after Sentinel Lymph Nodes (SLN).

• Management of classical type lobular carcinoma in situ (LCIS).

• Understanding surgical approaches.

• Understanding use of chemotherapy in relationship to receptor x genote status.

If you do not plan to implement any new strategies learned at this symposium, please list any barriers or obstacles that

might keep you from doing so.

• More patient education.

• I am a rheumatologist.

• I am neither a surgeon nor a medical oncologist.

• My status quo is okay.

• Insurance.

• Retired from surgical practice.

• Forensic Pathologist

• Topics do not directly refer to my practice.

• Semi retired.

• Availability of IORT.

Suggested topics and/or speakers you would like for future symposiums related to Breast Cancer Surgery.

• Breast reconstruction. (2)

• Genetics.

• Breast Cancer during pregnancy.

• Breast Cancer prevention.

• Genetic markers.

• Obesity diabetes.

• Talk on breast cancer from a primary care physician prospective.

• Genetic testing in breast cancer

• More diagnostic.

• Updates in build out of carrier institute.

• Nilza Kallos speaker regarding mammogram and tomosynthesis.

• Counseling and reliable information for newly diagnoses breast cancer patients.

• Different modalities of reconstruction.

• Surgical treatment of ductal carcinoma in situ (DCIS).

• Yearly updates.

• More in-depth on sentinel nodes.

Comments

• Great conference. (15)

• Excellent speakers. (5)

• Extremely informative. (3)

• Excellent presentations.

• Nice job.

• High quality.

• Topics are good.

• Useful seminar.

• Need legislation for coverage on 3D mammogram.

• I have a great deal of faith in our breast surgical, radiologist and pathology services

• I am an internist, helped me be updated in this topic.

• SMH auditorium is superior to the present venue.

• Should not use handheld microphones.

• Need to have mints, water and pens available for attendees.

• Need tables for attendees.

• Shorter talks as this is a Saturday.

• More breaks.

• It is sad that insurance companies (AETNA) do not reimburse for 3D mammogram.


Echocardiography Thirty-third Annual Symposium

Friday, October 31, 2014



FACULTY EVALUATION: 5- Excellent 4- Very Good 3- Good 2-Fair 1-Poor

Interpretation of Unusual Doppler Echo Strips

Itzhak Kronzon, M.D. 4.6

Diastolic Dysfunction

Allan Klein, M.D. 4.3

Role of Echocardiography in Assessing Patients Undergoing Transcatheter Aortic Valve Replacement

Partho P. Sengupta, M.D. 4.4

Low Flow - Low Gradient Severe Aortic Stenosis: Fact or Fiction?

Miguel A. Quiñones, M.D. 4.6

Is there a Role for Echocardiography in Cardiac Resynchronization Therapy in 2014?

Richard A. Grimm, D.O. 4.4

Congenital Hemodynamics: Beyond the Basics

Richard Humes, M.D. 4.5

Advances in Management of Valvular Heart Disease

Jamil Tajik, M.D. 4.6

Echocardiography in Atrial Fibrillation


Differential Diagnosis of Restrictive Cardiomyopathy versus Constrictive Pericarditis

Partho P. Sengupta, M.D. 4.4

Echocardiographic Guidance of Interventional Procedures for Structural Heart Disease: TAVR, E-clip, LAA

Closure and Paravalvular Leaks

Richard A. Grimm, D.O.

4.3

Pitfalls in Prosthetic Valve Assessment

Miguel A. Quiñones, M.D. 4.7

Hypertrophic Cardiomyopathy: Risk Assessment for Sudden Death

Jamil Tajik, M.D. 4.8

M-Mode Technique: What You Need to Know to Pass the NBME Exam!


Challenging Case: Testing Your Skills

Faculty and Audience Participation 4.4

OBJECTIVE EVALUATION: 5- Excellent 4- Very Good 3- Good 2-Fair 1-Poor

● Interpret unusual flow patterns and diagnose complex hemodynamic situations. 4.4

● Apply best practice protocols when assessing patients undergoing transcatheter aortic valve

replacement (TAVR). 4.3

● Examine the role of echocardiography before, during and after TAVR. 4.4

● Differentiate between low-flow severe aortic stenosis and low flow-moderate/mild aortic stenosis in

patients with depressed LV function. 4.6

● Recognize appropriate use of dobutamine stress in the evaluation of these patients, and the

implications in decision-making. 4.6

● Differentiate between real low-flow, normal EF-severe AS and pseudo low-flow, normal EF-severe AS

created by technical issues. 4.5

● Identify the clinical implications of low-flow, normal EF-severe AS. 4.5

● Describe the indications for echocardiography in the selection of patients for cardiac

resynchronization therapy. 4.4

● Examine the utility of echocardiography in optimizing CRT for heart failure and evaluating CRT non-

responders. 4.5

● Identify the hemodynamic factors which influence blood flow in the un-operated patient with

congenital heart disease 4.4

● Recognize how hemodynamic factors shape the timing and management of patients with congenital

heart lesions 4.3

● Implement a systematic approach to deriving important hemodynamic information using

echocardiography. 4.4

● Assess advantages and limitations of medical, surgical and interventional treatment options for

individual valvular heart disease cases. 4.4

● Recognize the usefulness and limitations of imaging techniques for assessing valvular heart disease. 4.4

● Analyze the pros and cons of catheter-based valve replacement/repair. 4.4

● Integrate current guidelines for optimal timing of intervention in valvular heart disease. 4.5

● Assess the role of transesophageal echocardiography in cardioversion and ablation of atrial fibrillation

AFib). 4.4

● Differentiate between restrictive cardiomyopathy and constrictive pericarditis utilizing proper imaging

techniques. 4.4

● Recognize the indications for TEE guidance in structural heart disease. 4.5

● Discuss the roles of TEE in the management and successful interventions of structural heart disease. 4.3

● Recognize the technical pitfalls that can result in a misdiagnosis of prosthetic valve dysfunction 4.3

● Employ the proper algorithm when evaluating prosthetic aortic and mitral valves. 4.3

● Cite the pitfalls associated with the assessment of TAVR. 4.4

● Explore the diverse views on the natural history and assessment of risk for sudden cardiac death 4.4

● Recognize the clinical, morphologic and genetic spectrum of hypertrophic cardiomyopathy. 4.3

● Identify mechanisms responsible for adverse clinical events and natural history. 4.4

● Interpret basic and advanced M-Mode tracings. 4.4

Total Average 4.4


Yes 87

No 0

No Answer 7


Echocardiography Thirty-third Annual Symposium

Saturday, November 1, 2014



FACULTY EVALUATION: 5- Excellent 4- Very Good 3- Good 2-Fair 1-Poor

Myocardial Mechanics: Assessment and Implications

Partho P. Senguta, M.D. 4.5

Postoperative Congenital Heart Disease

Richard Humes, M.D. 4.8

Evaluation of MR Severity: 3D Echo or CMR?

Miguel Quiñones, M.D. 4.7

Pericardial Disease: What is New?


Future of Echocardiography and Emerging Paradigms: Are We Going the Way of Robotics and

Mechanical Intelligence?

Partho P. Sengupta, M.D.

4.3

Hemodynamics Without Catheters: How to Extract All the Data from a Routine Doppler


2014 ACC/AHA Valvular Heart Disease Guideline Update

Richard A. Grimm, D.O. 4.7

OBJECTIVE EVALUATION: 5- Excellent 4- Very Good 3- Good 2-Fair 1-Poor

● Integrate myocardial mechanics into diagnostic algorithm. 4.0

● Define global and regional parameters for standardized assessment values. 4.2

● Examine surgical procedures to correct simple and complex congenital heart lesions. 4.4

● Analyze the techniques necessary to derive the echocardiographic information that is required for

proper evaluation of the congenital heart disease patient who has had corrective surgical procedures. 4.4

● Accurately quantify MR severity utilizing the optimal imaging technique. 4.5

● Recognize and compare the strengths and limitations of traditional 2D/Doppler methods, TEE and 3D

and cardiovascular magnetic resonance (CMR) for assessing severity. 4.5

● Evaluate the role of multimodality imaging of patients with pericardial diseases. 4.5

● Examine emerging paradigms in telemedicine, tele-echocardiography, robotic platform and

echoinformatics. 4.1

● Apply Doppler to make comprehensive hemodynamic assessment. 4.4

● Discuss echocardiography advances as represented at the 2014 Scientific Sessions. 4.5

● Apply new echocardiographic advances in the modern echo laboratory. 4.3

● Describe the potential clinical significance of recent advances in echocardiographic research. 4.3

Total Average 4.4


Yes 80

No 0

No Answer 0

CONTINUING MEDICA L EDUCATION DEPARTMENT

Thirty-third Annual Echocardiography Symposium

October 31-November 1, 2014

Overall Evaluation Summary



How many patients will you see in your practice next week that will likely be impacted by what you learned at this

symposium?

17 0-10(22%) 25 10-15 (33%) 10 15-20(13%) 7 20-25 (9%) 8 Over 25 (11%) 9 No Answer(12%)

Participation in this learning activity has:

Increased my knowledge 73 Yes 0 No 3 No Answer

Improved my competence 70 Yes 4 No 2 No Answer

Enhanced my performance 69 Yes 4 No 3 No Answer

Ensured that my patients will have improved outcomes 69 Yes 4 No 3 No Answer

This educational activity has contributed to my professional effectiveness and improved my ability to:

Scoring Key: 5 – Strongly Agree 4 – Agree 3 - Neutral 2 - Disagree 1 – Strongly Disagree

Treat/manage patients 4.4

Communicate with patients 4.0

Total Average 4.2


Overall impression of symposium. 4.4


(37%) Mail (28)

(25%) Email (19)

(5%) Poster (4)

(3%) DCMA (2)

(3%) Internet (2)

• Google

• Baptist

(38%) Other (29)

• Word of mouth (7)

• Colleague (7)

• Previous attendee (6)

(5%) No Answer (4)

Yes No No Answer

Have you attended this symposium in the past? (59) 78% (12) 16% (5) 7%


• Less CME hours.

• Usually do every 2 years.

Would you recommend this symposium to a colleague? (69) 91% (0) 0% (7) 9%

What do you intend to do differently in the treatment of your patients as a result of what you learned at this symposium? What

new strategies will you apply in your practice of patient care?

• Apply new techniques in diagnosis and management of diseases. (2)

• Continue to read and learn.

• Integrate several values for diagnosis.

• Apply better technique/approach to diagnosis.

• Spend more time with my echo technicians and teach more.

• LA function in patients with atrial fibrillation?

• Change parameters with Mrenal.

• Will utilize Dobutrex stress in evaluations of low output aortic stenosis (AS).

• Apply information in Echo readings in practice.

• Improve criteria for acute urinary retention (AUR).

• Consider earlier intervention.

• Quantification of valvular aortic stenosis.

• A few things I learned about atrial fibrillation and valvular disease.

• Apply optimal clinical and echocardiographic management.

• Request diastolic functions using more echo parameters; explore evaluation of cardiac resynchronization therapy (CRT) and

(Echo).

• Apply the new 2014 Valvular guidelines in treating patients.

• Apply updated clinical guidelines.

• Echo and assessment of aortic valve replacement (AVR).

• Use 3D Echo in assessing wall motion.

• Use new valve guidelines.

• Use M.R. evaluation

• Starting Tran catheter aortic valve replacement (TAVR) at our hospital. 3D evaluations will be used more.

• More aware of small details regarding various conditions.

• Better assess prosthetic valves.

• Implement strategies to refer for transcatheter aortic valve replacement (TAVR) vs. surgical aortic valve replacement (SAVR)

more frequently. Also transcatheter use of initial clips.

• Assessment of AS and MR for surgery.

• Use more strain echo.

• Apply mitral regurgitation (MR) evaluations.

• TAVR.

If you do not plan to implement any new strategies learned at this symposium, please list any barriers or obstacles that might

keep you from doing so.

• Most of this is known to me.

• Any way we have barriers.

• High price.

• Coordinating new techniques.

• I do not currently perform echo.

• Change in practice now treating less severe pathology.

• Myocardial mechanics, not clinical.

Suggested topics and/or speakers you would like for future symposiums related to Echocardiography.

• Congenital diseases. (3)

• Assessment of vascular disease and timing of surgery.

• Intra-vascular ultrasound.

• More information on congenial heart disease in adults.

• Proper evaluation of value function.

• Diastolic function in atrial fibrillation.

• Explanation (rather than assumption of knowledge) of echo assessment of diastolic function.

• Cardio oncology.

• More fractural and common problems like done by Dr. Kronzon.

• Keep updating topics with new researches.

• Need more talks that are practical rather than theatrical ones. Also more case reviews and management would be more

helpful.

• Pulmonic valve disease.

• Tricuspid valve disease.

• Echo in left ventricular assist device (LVAD).

• Congestive heart failure (CHF).

• Continue updates as they occur (pertinent advanced in field).

• Speckle/Strain echo.

• Workshops to provide how to perform and implement advanced techniques in 3D/4D echo.

• Diastolic assessment in atrial fibrillation.

Comments.

• Good meeting. (2)

• Excellent Symposium. (2)

• Excellent quality speakers, media/visuals and topics. (2)

• Well done conference.

• Very helpful.

• 30 minute lectures were very good.

• Focus more on a general cardiological audience.

• I would suggest that you offer a CD of slides in packet or early download. You need to offer more electrical outlets and then

we can follow on our own laptops or pads.

• Acoustic very poor.

• Speaker too loud and volume set too high.

• Most of the speakers could benefit from presentation training; words and phrases are blurted out; comments are dipped off

and/or shouted.

• WiFi did not work. Locked out twice.

• AV technical problems – why?

• No breakfast or other pastelitos at break or lunch. Very cheap this year.

• Screen on left out of focus. This year the slides were such that it was hard to appreciate what was being shown. (2)


Twelfth Annual Sleep Center Symposium November 15, 2014



Can We Truly Control Our Dreams?

Timothy L. Grant, M.D., M.D. , FAASM 4.9

• Explain sleep architecture and the electrophysiology of dreams. 4.9

• Identify different types of dreams and how they relate to sleep disorders. 4.9

• Implement appropriate treatment options for dream related sleep disorders. 4.9

Update on Sleep Apnea

Jeremy I. Tabak, M.D. FCCP, FAASM 4.8

• Evaluate patients with sleep apnea and provide appropriate treatment recommendations incorporating

new treatment modalities. 4.8

• Describe the role of polysomnography in a patient with suspected sleep apnea. 4.7

Sleep Apnea, Arrhythmias and Sudden Death

Virend K. Somers, M.D., Ph.D 4.9

• Identify cardiovascular disease mechanism activated by sleep apnea. 5.0

• Discuss the role of the driving reflex in bradyarrhythmias triggered by sleep apena. 5.0

• Describe the association between sleep apnea, myocardial ischemia and cardiac arryhythmias. 4.9

• Examine the interaction and mechanisms linking sleep apnea and sudden death. 4.9

Cognitive Behavior Therapy and CPAP Compliance

Marcy Wasman, Ph.D. 4.8

• Identify behavior patterns associated with CPAP compliance issues. 4.8

• Implement cognitive behavior therapy to optimize CPAP adherence. 4.8

Hypoglossal Nerve Stimulator – New Techniques for Sleep Apnea Patients

Rolando Molina, M.D. 4.9

• Identify the anatomical levels involved in the management of obstructive sleep apnea (OSA). 4.9

• Define the role of surgery in the management of OSA patients. 4.9

• Explain the role of neurostimulation of the tongue to treat OSA. 4.8

Sleep Deprivation and Cardiometabolic Dysregulation – Does Sleeping less make you fat?

Virend K. Somers, M.D. Ph.D 5.0

• Connect epidemiologic evidence linking sleep deprivation to weight gain and cardiovascular risks. 5.0

• Identify effects of sleep deprivation on energy intake and expenditure. 5.0

• Explain mechanisms linking sleep deprivation with weight gain and cardio-metabolic dysfunction. 4.9

Sleep and Neuro-degenerative Disorders

David Seiden, M.D. 4.7

• Identify common sleep disturbances occurring in various neurodegenerative states. 4.7

Total Average 4.9

Was this Symposium fair, balanced, and free of commercial bias?

• There was referral bias by Dr. Molina.

Yes 59

No 1

No Answer 4


(47%) Email (30)

(45%) Mail (29)

(5%) Internet (3)

(19%) Other (12)

How many patients will you see in your practice next week that will likely be impacted by what you learned at

this symposium? (63 responses to this question)

25 1-5 (39%) 8 6-10 (13%) 14 Over 10(22%) 15 Not Applicable (23%) 2 No Answer(3%)

What do you intend to do differently in the treatment of your patients as a result of what you learned at this conference? What

new strategies will you apply in your practice of patient care?

• Consider more sleep referrals. (4)

• Inquire more about sleep patterns. (2)

• Good evaluation of patients with symptoms and risk factors for Obstructive Sleep Apnea (OSA) to determine

who should go to Polysomnography to confirm diagnosis of Obstructive Sleep Apnea (OSA) and try to reverse

metabolic abnormalities of Obstructive Sleep Apnea (OSA). (2)

• Use knowledge acquired to improve patient care. (2)

• Emphasize importance of adequate sleep.

• Describe sympathetic response in Obstructive Sleep Apnea (OSA) to patients.

• Better history.

• Identify and improve Continuous Positive Airway Pressure (CPAP) compliance.

• Update what is proven by Evidence Based Medicine (EBM) for sleep disorders.

• Adopt a post Pulmonary Artery Pressure (PAP) titration questionnaire to predict Pulmonary Artery Pressure (PAP)

failure.

• Plug it into my practice.

• Better follow up of patients to Continuous Positive Airway Pressure (CPAP). Consider Cognitive Behavior

Therapy (CBT) for resistant patients and consider hypoglossal nerve stimulation for patients who refuse

Continuous Positive Airway Pressure (CPAP).

• Measure Cardiac Resynchronization Therapy (CRP).

• All Dr. Wasman’s recommendations will be applied.

• More focus patient approach.

• More sleep study.

• Better educate patients on issues related to sleep deprivation.

• Post Dramatic Stress Disorder and sleep.

• Traumatic Brain Injury and sleep.

• Encourage extension of sleep time.

• Screen patients for Obstructive Sleep Apnea (OSA). Assist with compliance.

• I refer patient and sleep problem to be evaluated.

• Get more details on sleep habits and problems and refer to sleep studies.

• As a dermatologist I don’t have a lot of direct use of the information learned at this conference however,

should my patients complain of possible sleep disorders I can be aware of them and refer for treatment or if

patient already diagnosed with a sleep disorder I am better informed about their condition.

• Get tested for sleep apnea.

• Lose weight! Will better educate patients on sleep apnea.

• Cognitive Behavior Therapy (CBT) prior to Pulmonary Artery Pressure (PAP) treatment.

• Evaluate more patients for sleep apnea.

• Encourage aggressive treatment of obesity.

If you do not plan to implement any new strategies learned at this conference, please list any barriers or obstacles that might

keep you from doing so.

• Phenotypes of OSA as a treatment selection tool. (2)

• To be determined.

• None I already do it.

• Sleep related seizures.

• Refer patient to sleep centers.

• More about Continuous Positive Airway Pressure (CPAP).

• Semi retired.

• Forensic pathologist

List topics related to this lecture that you want to learn more about:

• Atul Malhotra, David White and Danny Eckert.

• Insomnia treatment by acupuncture.

• Studies on people who can stay away for extreme times.

• Insomnia in general.

• Sleep disruption and alcohol substances.

• More cases to be discussed.

• Repeat this one. It’s excellent.

• Repeat and update this one.

• Bring back Dr. Somers.

Comments:

• Excellent.(13)

• Great Baptist presentation.(4)

• Great speakers (3)

• Good conference. (2)

• Best Sleep Center symposium yet. Outside speaker, Dr. Somers was wonderful.

• Congratulations Sleep Center symposium is improving yearly.

• Conference was superb. Especially Dr. Somer’s elegant presentations.

• Will continue to attend on a yearly basis.

• A lot of info and treatment methods.

• Great Dr. Grant.

• Dr. Somer’s was outstanding.

• Best sleep symposium to date.

• Interesting learning experience.

• I have Obstructive sleep apnea.

• Too early. Would be nice if speakers had bullet points on their presentations.

• Audio visual supporters may need more education.

• Insomnia as a topic was absent.

• Dr. Molina made a big mistake. No speaker should use his/her own personal references. I am a sleep doctor

and I take offense at his comment.


Second Annual Miami Neuro Nursing Symposium

December 4, 2014



Overview of Clinical Evaluation and Management of Central and Peripheral Nervous System Tumors

Sergio Gonzalez-Arias, M.D., Ph.D., FAANS, FACS 4.9

• Differentiate benign and malignant brain and spinal tumors. 4.7

• Examine current surgical treatment modalities for brain and spinal tumors. 4.8

• Review ongoing research of novel treatment methods. 4.8

Traumatic Brain Injury

Mary Kay Bader, R.N., MSN, CCNS, CNRN, CCRN, FAHA 4.9

• Identify the pathophysiological changes following severe brain injury, and correlate these changes to

secondary brain injury. 4.6

• Prioritize the interventions used to manage intracranial pressure (ICP) and brain oxygen. 4.6

• Apply the Brain Trauma Injury Foundation guidelines to clinical practice. 4.4

• Demonstrate how to use the Bedside Shivering Assessment Score and maintain normothermia. 4.7

• Apply interventions to maximize the patient’s emergence through coma. 4.7

Current Treatment for Glioblastoma Multiforme (GBM)

Danette Birkhimer, R.N., M.S., CNS, AOCNS 4.7

• Examine the mechanism of actions of tumor-treating fields (TTFs) for the management of gliblastoma

multiforme. 4.6

• Review current applications and approved uses of TTFs and describe the nursing role in therapy. 4.7

Inside the Black Box: ICP and Multi-modality Monitoring in the Neuro Critical Care Patient

Mary Kay Bader, R.N., MSN, CCNS, CNRN, CCRN, FAHA 4.7

• Identify the causes of increased ICP, and define the normal/abnormal values. 4.9

• Relate the pathophysiological changes in elevated ICP to their clinical manifestations. 4.6

• Differentiate between the types of ICP monitoring and Cerebrospinal Fluid drainage systems. Identify the

interventions for reducing ICP in stroke patients with malignant cerebral edema as well as TBI patients. 4.6

• Utilize a pupillometer – a noninvasive device for ICP monitoring – in stroke patients to measure cerebral

swelling and potential increases in ICP. 4.6

Cardioembolic Strokes

Kendra Menzies Kent, M.S., RN-BC, CCRN, CNRN, SCRN 4.9

• Identify risk factors for cardioembolic stroke. 4.8

• Manage atrial fibrillation issues including rate-control and rhythm control. 4.6

• Identify common territory for a cardioembolic stroke and discuss the pathophysiology, 4.8

• Implement appropriate initial management of cardioembolic strokes in the emergency department

including use of thrombolytics. 4.7

• Discuss the current recommendations for primary and secondary prevention of cardioembolic strokes. 4.9

Telestroke Care: Instant Evidence-based Expertise

Brett C. Meyer, M.D. 4.6

• Identify the resource shortage regarding acute stroke management. 4.7

• Describe techniques, systems and workflows regarding acute telestroke care. 4.7

• Review the evidence for reliability of performing neurologic examinations using telestroke care. 4.8

• Evaluate the data related to rt-PA administration and telestroke care. 4.7

• Recognize the evidence for efficacy for acute stroke decision making using telestroke care. 4.8

Thrombotic Ischemic Strokes: Care Through Rehabilitation

Kendra Menzies Kent, M.S., RN-BC, CCRN, CNRN, SCRN 4.9

• Discuss the pre-hospital guidelines for timing and assessment of patients with neurological changes. 4.9

• Determine the initial management of a patient presenting with an ischemic thrombotic stroke in the

emergency department, including appropriate radiological studies. 5.0

• Delineate the indications for administering thrombolytics including the extension to 4.5 hours with new

exceptions. 4.9

• Describe the interventional options for a thrombotic ischemic stroke patient. 4.9

• Identify primary goals and management of a thrombotic stroke patient within the ICU and acute care

settings. 4.9

Total Average 4.8


• Nothing listed.

Yes 11

No 0

No Answer 5


• Be more cautious.

• Suggest clinical trials/retrospective study on our telestroke network.

• Importance of pupilometry.

Suggested topics and/or speakers you would like for future symposiums related to Neuro Nursing.

• Hyperthermia for stroke treatment.

• Differentiation between radiation necrosis and tumor recurrence by MR spectroscopy.

Comments

• Excellent symposium.

• Great review.

• Dr. Gonzalez-Arias’ presentation was interesting.

• The Telestroke lecture was interesting.


2014 Miami Neuro Symposium Friday, December 5, 2014



Diagnosis and Treatment of Catastrophic Epilepsy: Multidisciplinary, Multi-modality and Multistage Approach

Ki Hyeong Lee, M.D. 4.7

• Examine catastrophic epilepsy and drug-resistant epilepsy with epileptic encephalopathy, and recognize

the common causes. 4.7

• Determine treatment options based on the causes and severity of catastrophic epilepsy. 4.6

• Explain the pathophysiology of epileptic encephalopathy. 4.5

• Discuss the limitations of individual localization tools and the need for multimodality approaches to

treatment. 4.6

Transcranial Magnetic Stimulation for Functional Mapping and Uses in Epilepsy

Malek Adjouadi, Ph.D. 4.4

• Recognize the functional capabilities of transcranial magnetic stimulation (TMS) for mapping the eloquent

cortex of the brain. 4.3

• Assess the merits of TMS in developing protocols with safety considerations for potential therapeutic

interventions in epilepsy. 4.4

Surgical Options in the Management of Intractable Epilepsy: Current Review

Fernando Vale, M.D. 4.8

• Describe current surgical options for the management of medically-resistant epilepsy. 4.8

• Explain the pre-operative work-up and the selection process for surgical intervention. 4.7

Minimally Invasive Strategies for Epilepsy Treatment

Prasana Jayakar, M.D., Ph.D. 4.4

• Define the epileptogenic target – the area that needs to be ablated to control seizures. 4.5

• Explore existing and emerging technologies to enhance safety and efficacy of focal ablation. 4.5

Management of Malignant Brain Tumors: Clinical Best practices and Research Update

Henry Friedman, M.D. 4.8

• Delineate strategies for making a proper evaluation of the brain tumor patient and determination of clinical

manifestations. 4.8

Nanoparticle-based Drug Delivery Systems Can Overcome the Challenge of the Blood-Brain Barrier

Anthony McGoron, Ph.D. 4.5

• Evaluate the state-of-the-art of nanoparticle drug delivery for brain cancer treatment. 4.5

• Recognize the mechanisms for drug transport across the blood brain barrier and examine current methods

for overcoming those barriers. 4.5

• Examine in vitro models of the blood brain barrier used to screen drugs and drug delivery systems intended

to treat neurological diseases. 4.5

Evidence-based Management of Brain Metastases

William Friedman, M.D. 4.7

• Consider the level I and level II evidence for brain metastasis treatment. 4.8

• Examine the role of radiosurgery in the treatment of brain metastases. 4.8

Radiosurgery Management of Arteriovenous Malformations

L. Dade Lunsford, M.D. 4.9

• Examine the indications for radiosurgery in the management of brain ArteriovenousMalformations (AVM). 4.9

• Review expected outcomes, risks, and benefits of radiosurgery treatment of AVM. 4.9

Radiosurgery for Vestibular Schwannoma 4.9

William Friedman, M.D.

• Examine the role of radiosurgery in the treatment of vestibular Schwannoma and assess the risks and benefits

of compared to open surgery. 4.9

Functional Radiosurgery: Coming Full Circle

L. Dade Lunsford, M.D. 4.9

• Discuss the application of stereotactic radiosurgery (SRS) as a technique for treatment of trigeminal

neuralgia and movement disorders. 5.0

• Delineate patient selection criteria, indications for use, benefits and potential drawbacks of SRS for

movement disorders and trigeminal neuralgia. 4.9

Brain Tumors: When Should Radiosurgery be Adjuvant?

Vitaly Siomin, M.D. 4.8

• Examine the role of radiosurgery as an adjuvant treatment strategy, and explore potential benefits such as

avoiding potential toxicity of WBRT and improving local control. 4.8

• Assess the effectiveness of radiosurgery adjuvant treatment as a strategy for delaying and even foregoing

whole-brain radiotherapy. 4.8

Total Average 4.7


• Nothing listed.

Yes 25

No 0

No Answer 5


2014 Miami Neuro Symposium Saturday, December 6, 2014



Update on Neuroimaging: Focus on Perfusion Imaging in Stroke

Kevin Abrams, M.D. 5.0

• Determine when perfusion imaging is useful in assessment and treatment of acute stroke. 5.0

• Evaluate the limitations and potential pitfalls of using perfusion imaging in assessment of acute 5.0

Focus on Unruptured Brain Aneurysms

Guilherme Dabus, M.D. 5.0

• Evaluate non-surgical treatment methods for unruptured brain aneurysms, and discuss safety and efficacy

compared to surgical treatment. 5.0

Treatment of Craniofacial Arteriovenous Malformation

Guilherme Dabus, M.D. 4.9

• Apply optimal treatment strategies in patients with unruptured intracranial aneurysms considering the risks vs.

benefits of treatment vs. non-treatment. 4.9

Acute Stroke Intervention

Italo Linfante, M.D. 4.8

• Review the concept and technical aspects for acute stroke intervention. 4.9

Next-generation Devices to Treat Aneurysms and Stroke

David Fiorella, M.D., Ph.D. 5.0

• Describe contemporary strategies for the treatment of acute aneurysms and stroke. 5.0

• Evaluate potential treatment devices for the minimally invasive evacuation of intracranial hemorrhage. 5.0

• Recognize potential utility of new devices for the treatment of wide necked bifurcation aneurysms. 5.0

Review of Clinical Trials: PUFS, INTREPED, SCENT and FRED

Italo Linfante, M.D. 4.9

• Apply optimal treatment strategies in patients with unruptured intracranial aneurysms considering the risks vs.

benefits of treatment vs. non-treatment. 4.9

Spinal Vascular Shunts: Symptoms, Classification and Treatment

Ajay Wahkloo, M.D., Ph.D. 4.9

• Identify the various neurological symptoms associated with spinal arteriovenous (AV) shunts. 4.9

• Define the classifications of spinal AV shunts and recognize their distinct treatment strategies. 4.9

• Examine the value of various imaging modalities in the diagnosis of spinal AV shunts. 4.9

Advanced Imaging in Neurovascular Suite

Ajay Wahkloo, M.D., Ph.D. 4.9

• Demonstrate the use of newer imaging technologies introduced and added to the neuroangiography suite

to treat complex neurovascular lesions including acute ischemic and hemorrhagic stroke and expound

technical feasibility and possible applications.

4.9

Case Studies in Neuroimaging

Kevin Abrams, M.D. 5.0

• Recognize MR imaging features distinguishing between infection and infarction. 5.0

• Review utility of MR perfusion in differentiating between infection and tumor. 5.0

Sedation and Delirium in the Neurocritical Care Unit

Javier Provencio, M.D. 4.9

• Recognize unique patient care challenges delirium presents including detection of life- threatening

neurological events and pain management. 4.9

• Identify reliable screening methods and treatment strategies for managing pain, agitation and delirium in

the neurocritical care unit. 4.9

Approach to the Comatose Patient

Karel Fuentes, M.D. 4.9

• Appropriately evaluate, diagnose and treat the comatose patient. 4.9

Multimodal Monitoring in the Neuro ICU

Javier Provencio, M.D. 4.9

• Examine new and emerging multimodal monitoring techniques, and identify the benefits of their use in the

Neuro ICU. 4.8

Traumatic Brain Injury

Kristine O’Phelan, M.D. 4.9

• Describe the mechanisms of primary and secondary injury following acute traumatic brain injury (TBI). 5.0

• Recommend an individualized approach to elevated intracranial pressure in a patient with TBI. 4.9

Acute Spinal Cord Injury

Kristine O’Phelan, M.D. 4.9

• Identify the mechanisms of primary and secondary injury following acute spinal cord injury. 4.9

• Implement strategies to wean acute spinal cord injury patients from mechanical ventilation. 4.8

Total Average 4.9


• Nothing listed.

Yes 19

No 1

No Answer 7

CONTINUING MEDICAL EDUCATION DEPARTMENT 2014 Miami Neuro Symposium

December 5-6, 2014

Physician Overall Evaluation Summary






• Location 4.5



Total Average 4.7


(32%) Internet (8)

(24%) Email (6)

(20%) Mail (5)

(12%) Other (3)

(20%) No Answer (5)

Yes No No Answer

Have you attended this symposium in the past? (12) 48% (13) 52% (0) 0%



• No comments.

(23) 92% (1) 1% (1) 1%





Manage my medical practice 4.6

Total Average 4.6






How many patients will you see in your practice next week that will likely be impacted by what you learned at this

symposium? (63 responses to this question)

12 1-5(48%) 4 6-10 (16%) 4 Over 10 (16%) 5 Not Applicable(20%)


What new strategies will you apply in your practice of patient care?

• Generally accommodate more readily newer strategies.

• Reconsider Glioblastoma Multiforme (GBM).

• Apply to the guidelines for treatment of Epilepsy.

• Diagnostic tools.

• Earlier endovascular Brain Arteriovenous Malformations (AVMs).

• Referral of patients with refractor cluster headaches for stereotactic radiosurgery (SRS) (gamma knife).

• Earlier role of SRS.

• Effectiveness of SRS versus other modalities.

• Use of radiosurgery for tremors.

• May use retigabine in selected cases.

• Consider sub-type of stroke.

• Differentiation between radiation necrosis and tumor recurrence by MR spectroscopy.

• Help to develop checklists.

• Increase referrals for surgery workup for epilepsy patients.

If you do not plan to implement any new strategies learned at this symposium, please list any barriers or obstacles that

might keep you from doing so.

• Patients insurance.

• Cost availability.

Suggested topics and/or speakers you would like for future symposiums related to Neuro.

• Multiple Sclerosis (MS). (2)

• New versus old MS drugs.

• Radiation therapy for central nervous system (CNS) in depth.

• Essential tumor and Parkinson’s disease – Michael Okun, M.D.

• Parkinson’s and Migraine.

• New Epilepsy drugs.

• Pain Management.

• Review old and new Imaging.

• New treatments: chronic pain, dementia, stoke prevention (Ischemic).

• Sinus thrombosis.

• Carotid endarterectomy.

• Neuromuscular Diseases.

• Hands on neurocritical.

• Consider more basics for neurocritical.

• Primary prevention of stroke and secondary stroke prevention.

• Radiosurgery.

Comments.

• The best symposium.

• Traumatic brain injuries presentation was excellent.

• Exciting new data. Very up to date.

• If possible have 2 screens on the sides or larger screens for better viewing.

• Different location for the meetings.


Inaugural Venous Thromboembolism Symposium Saturday, December 13, 2014

Physicians Attended: 79 Physicians Responded: 75

FACULTY EVALUATION : 5- Excellent 4 - Very Good 3 - Good 2 -Fair 1-Poor

Clinical Use of the New Oral Anticoagulants Ian del Conde Pozzi, M.D.

4.8

Thrombophilia Testing: What, When and Whom to Test? Adam Cuker, M.D.

4.9

What to do with Line -Associated Deep Vein Thrombosis (DVT), Calf Vein DV T, and Superficial Vein Thrombosis? Ian del Conde Pozzi, M.D.

4.8

Diagnosis, Management, and Disposition of Patients with DVT in the ER Adam Cuker, M.D.

4.8

Overview of Endovascular Therapies for VTE: Availab le Devices and Techniques Shaun Samuels, M.D.

4.6

Which Patients with Lower Extremity DVT Benefit Fro m Endovascular Therapy? Alex Powell, M.D.

4.8

IVC Filters: Expected Outcomes, Co ntroversies and Indications Constantino Peña, M.D.

4.8

Evaluation and Management of Upper Extremity DVT James Benenati, M.D.

4.8

Rationale for Thrombolysis in Pulmonary Embolism Ian del Conde Pozzi, M.D.

4.8

New Interventional Therapies for Pulmonary Embolism Ripal Gandhi, M.D

4.8

Cases from the MCVI Archives Constantino Peña, M.D., and James Benenati, M.D.

4.8

OBJECTIVE EVALUATION : 5- Excellent 4- Very Good 3- Good 2-Fair 1-Poor

• Implement clinical evaluation strategies that promote early identification of VTE. 4.8

• Advance early detection of VTE by implementing recommended clinical evaluation strategies. 4.8

• Apply evidence-based strategies to improve outcomes for the VTE patient. 4.8

• Improve outcomes for VTE patients by applying new evidence-based treatment strategies. 4.8

• Examine and assess the use of new anticoagulants and explore the value of endovascular therapies for VTE.

4.8

• Identify new oral anticoagulants approved by the FDA for the treatment and prevention of VTE, including their indications, contraindications, approved doses and necessary dose adjustments.

4.8

• Discuss the basic pharmacokinetics and pharmacodynamics of approved new oral anticoagulants and analyze the clinical evidence behind the use of these agents in VTE.

4.7

• Determine when testing for underlying thrombophilia is indicated. 4.7

• Discuss the specific thrombophilia tests that can be ordered, their correct interpretation and limitations. 4.7

• Recognize when results of a thrombophilia evaluation change the clinical management of VTE patients.

4.8

• Discuss the indications for anticoagulation surveillance using duplex ultrasound. 4.7

• Recognize the diverse nature of pathologies that can present as upper extremity DVT. 4.7

• Implement a basic evaluation strategy for patients with upper extremity DVT, including appropriate use of imaging modalities, specifically duplex ultrasound and MR/CT venography.

4.7

• Examine the management of various VTE etiologies. 4.8

• Discuss the evolution and development of interventional therapies for VTE. 4.7

• Examine the basic components of interventional therapies for VTE, including access, general description of the main procedures used, basic procedural risks and complications.

4.7

• Examine the basic components of interventional therapies for VTE, including access, procedural overview and potential risks and complications.

4.7

• Discuss endovascular therapeutic approaches to VTE management, including specific devices and techniques employed.

4.6

• Identify signs and symptoms of severe venous outflow obstruction. 4.8

• Perform a basic evaluation on a patient with iliofemoral DVT, including appropriate use of different imaging and diagnostic modalities.

4.8

• Examine the basic clinical aspects of post-thrombotic syndrome, including risk factors, clinical presentation and management.

4.8

• Identify patients with acute lower extremity DVT who may benefit from endovascular therapy. 4.8

• Discuss the basic clinical aspects of the May-Thurner syndrome and other syndromes caused by extrinsic venous compression.

4.7

• Discuss the indications and contraindications for the use of IVC filters. 4.8

• Recognize the expected benefits and risks of IVC filter use. 4.8

• Distinguish the official recommendations of the different multidisciplinary guidelines on the use of IVC filters.

4.8

• Describe the IVC filter placement procedure. 4.6

• Discuss pretest probability for diagnosis of DVT. 4.8

• Determine when patients should be evaluated with duplex ultrasound. 4.9

• Identify patients with DVT who can be safely discharged from the ER. 4.8

• Describe the rationale and clinical evidence behind thrombolysis (systemic and catheter-directed) for the treatment of acute pulmonary embolism.

4.8

• Implement appropriate strategies to risk-stratify patients with PE, including the use of chest CT angiography, biomarkers and echocardiography.

4.7

• Identify which patients are at increased risk of poor outcomes. 4.7

• Discuss the current status of the field of interventional therapies for PE, including results of the most recent clinical trials.

4.8

• Analyze the indications and contraindications for implementation of interventional therapies for PE. 4.8

• Examine various types of interventions for PE, including thrombolysis, mechanical thrombolysis and suction embolectomy.

4.8

Total Average 4.8


Yes 66 No 0 No Answer 9


Inaugural Venous Thromboembolism Symposium Saturday, December 13, 2014

Overall Evaluation Summary






• Location 4.7



Total Average 4.7


(45%) Email (33)

(40%) Mail (29)

(12%) Internet (9)

(8%) DCMA (6)

(8%) Poster (6)

(1%) Facebook (1)

(5%) Other (4)

(7%) No Answer (5)

Yes No No Answer

Would you attend this symposium again next year?

• Live out of town.

• I am retired.

(69) 95%

(2) 3%

(2) 3%


(69) 95%

(1) 1%

(3) 4%





Manage my medical practice 4.7

Total Average 4.8






How many patients will you see in your practice next week that will likely be impacted by what you

learned at this symposium? (63 responses to this question)

46 0-10(63%) 12 10-15 (16%) 5 15-20(7%) 2 20-25 (3%) 0 Over 25 (0%) 8 No Answer(11%)

What do you intend to do differently in the treatment of your patients as a result of what you learned at this

conference? What new strategies will you apply in your practice of patient care?

• Consider different oral agents. (4)

• Refer patients quickly for vascular evaluation intervention. (3)

• Use more aggressive prophylaxis and start using the new dressings for treatment (TX) of deep venous

thrombosis (DVT). (3)

• Enhanced my knowledge for use and indications for new oral anticoagulents as well as evaluation of Venous

Thromboembolism (VTE). (2)

• Anticoagulation management. (2)

• Less workup for thrombophilia. (2)

• Prompt referral to proper ER department and/or specialist. (2)

• Best approach to diagnosis and treatment.

• Direction of anticoagulation and identify appropriate anticoagulant treatments.

• More confident in explaining treatment options and outcomes to patients.

• Refer to Miami Cardio Vascular Institute (MCVI) module.

• Understand the role for intervention vs. pharmacological treatment.

• Emphasize on intravenous cholangiogram (IVC) filter removal.

• Education of patients.

• Refer patients to hematologist.

• I will follow the recommendations.

• Ask more questions.

• Obtain more details regarding symptoms.

• Earlier diagnosis and treatment of VTE.

• Read new invasive vascular lab at Doctors Hospital.

If you do not plan to implement any new strategies learned at this conference, please list any barriers or

obstacles that might keep you from doing so.

• Managed care.

List topics related to this lecture that you want to learn more about:

• Malignancy and venous thromboembolism (VTE).

• Follow-up on oral anticoagulant usage, etc.

• Preoperative management of anticoagulation.

• Venous treatment of varicose veins.

• More on the current anticoagulants out there.

• More review of randomized trials that exist.

• Promote simulation training for acute pulmonary embolus, (PE)

• STAT response team building

• Team training.

• ENT, head and neck.

• More on pulmonary embolus (PE).

• More on aspiration and suction of clot.

• How common is venous thromboembolism (VTE) in a general drug control user program (DCP)? To be

included in the program.

• Pelvic thrombophlebitis

• Atrial fibrillation.

Comments:

• Excellent symposium. (13)

• Very well organized.(4)

• Speakers were great. (4)

• Very good symposium.(2)

• Maybe have the conference more often or a full day.(2)

• Very pleased with the conference and will attend next year.

• Very informative, great speakers. Consider having online thumb drive access to lectures or pertinent

portions of them.

• Pulmonary embolism portions provided excellent clinical information.

• A great overview of the multiple issues that face the treatment of Venous Thromboembolism (VTE).

• Good presentation.

• Of all Baptist Health symposiums, this one in particular, will increase doctor’s knowledge and benefit

patient outcomes.

• Moderator was outstanding.

• I am a family physician from Kansas and plan to recommend this conference to other providers in the

coagulation clinic that I am involved with.

• I will refer colleagues to this conference.

• Appreciated having speakers from different specialties.

• Would have wanted a hematologist/oncologist present on more of the presentations (not just on

panel discussion).

• There was a lack of surgeon speakers re this topic, especially Orthopedic.

• Need Desk space.

• Some slides and speakers need to go slower.

• Too many topics and just 15 minutes for each speaker.(2)

• Tried to fit in too much too fast. (2)

• Speakers/conference need inclusion of handouts and bullet points. (3)

Documents

2015 February Evaluation Summaries - Baptist Health South ... · 2. Effectiveness of learning aids used (audio-visual, etc.) 3. Conference content. 4. Effectiveness of the speaker: